Peter Edman new Chief Scientific Officer at Biovitrum AB
Peter Edman, PhD, Associate Professor, 54, will join Biovitrum as Chief Scientific Officer. He is leaving his current position as Vice President and Global Project Director, Global Development, at AstraZeneca.
Peter Edman has previously held a number of senior research leadership positions within Pharmacia, Astra and AstraZeneca. He has also held a position as Director and Associate Professor at the Swedish Medical Product Agency. In addition, Peter Edman has comprehensive scientific qualifications from the University of Uppsala, which has rendered him a Ph.D. and an Associate Professor title in biochemistry. Moreover, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, Uppsala University.
Peter Edman will assume his position during the second quarter 2008.
Other news from the department people
![Newsletter](https://img.chemie.de/assets/bionity/images/newsletter.png)
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.